Eosinophilic Fasciitis – Report of Three Cases and Review of the Literature

Authors

  • Uwe Wollina Städtisches Klinikum Dresden, Department of Dermatology and Allergology, Dresden, Germany
  • Gesina Hansel Städtisches Klinikum Dresden, Department of Dermatology and Allergology, Dresden, Germany
  • Jacqueline Schönlebe Institute of Pathology "Georg Schmorl", Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany
  • Birgit Heinig Center of Physical and Rehabilitative Medicine, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany
  • Ivanka Temelkova Onkoderma - Clinic for Dermatology, Venereology and Dermatologic Surgery, General Skobelev 26, 1606, Sofia, Bulgaria
  • Georgi Tchernev Onkoderma - Clinic for Dermatology, Venereology and Dermatologic Surgery, General Skobelev 26, 1606, Sofia, Bulgaria
  • Aleksandra Vojvodic Department of Dermatology and Venereology, Military Medical Academy of Belgrade, Belgrade, Serbia
  • Torello Lotti University of Rome Guglielmo Marconi Rome, Italy

DOI:

https://doi.org/10.3889/oamjms.2019.296

Keywords:

Eosinophilic fasciitis, Fibrotic disorders, Scleroderma, Treatment, Corticosteroids, Methotrexate

Abstract

BACKGROUND: Eosinophilic fasciitis is a rare fibrosing disorder of muscle fascia with rapid onset of erythema, induration, oedema and tenderness affecting extremities bilaterally.

CASE REPORT: We report three cases of eosinophilic fasciitis in 3 females aged 64, 65 and 73 years, in two of them in association with morphea. They fulfilled the proposed diagnostic criteria. Associated malignancies could be excluded in all of them. They were treated by systemic corticosteroids. In the two females with associated morphea higher prednisolone dosages and a combination with methotrexate was necessary.

CONCLUSIONS: Eosinophilic fasciitis is a differential diagnosis of systemic scleroderma. Response to treatment is often delayed. Systemic corticosteroids are the first line therapy. Patients with associated morphea need combined drug therapy, in our patients with methotrexate. There is no close correlation between laboratory signs of inflammation and clinical response to treatment.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

Published

2019-05-15

How to Cite

1.
Wollina U, Hansel G, Schönlebe J, Heinig B, Temelkova I, Tchernev G, Vojvodic A, Lotti T. Eosinophilic Fasciitis – Report of Three Cases and Review of the Literature. Open Access Maced J Med Sci [Internet]. 2019 May 15 [cited 2022 Jan. 24];7(18):2964-8. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.296

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>